Work Here?
Overview
West Cancer Center provides comprehensive cancer care with access to Phase I–III clinical trials through a partnership with Methodist Healthcare and the University of Tennessee Health Science Center. Patients receive standard cancer care and may enroll in trials, while clinicians and researchers collaborate across the lab and clinic to develop and apply new therapies. This collaboration gives patients early trial access and a lab-to-clinic workflow that ties research directly to treatment. The goal is to improve cancer outcomes by speeding up research and turning findings into effective, evidence-based therapies for patients.
About West Cancer Center
Industries
Education
Healthcare
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Brighton, Colorado
Founded
1979
Get referred to West Cancer Center
See people who can refer or advise you
Simplify's Take
What believers are saying
- April 7, 2026 IDEOlogy partnership improves physician and APP education across West's network.
- July 28, 2026 ChoICE trial makes West the first U.S. site for ProSense cryoablation.
- May 2026 Bartlett expansion and dermatology clinic broaden access and strengthen local market share.
What critics are saying
- Atlas assumes full medical cost risk; poor utilization management hits West's referral economics by 2027.
- The DOJ Methodist kickback case still stains West's legacy and repels payer or partner trust.
- One-employer concentration in Memphis exposes West to hiring shocks and competitor poaching in 2026.
What makes West Cancer Center unique
- 46 years in Memphis with 113 providers and 68,000 annual patients on April 7, 2026.
- West combines UTHSC, Methodist, and OneOncology relationships with active research and clinical trials.
- The April 2026 Atlas launch makes West a flagship site for value-based oncology experimentation.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Company News
Advancing breast cancer care with cryoablation therapy. Jul 28th, 2026 West Cancer Center is so proud to announce the launch of a groundbreaking clinical study with IceCure Medical, making its network the 1st U.S. clinical site for the company's ProSense(R) cryoablation technology. The ChoICE Study will evaluate the use of ProSense(R) cryoablation in low-risk breast cancer patients, enrolling approximately 400 patients across 30 clinical sites nationwide. This important research will help gather real-world data and advance the use of innovative, minimally invasive treatment options for eligible patients. This technology, which has received FDA approval for use in patients age 70 and older with low-risk breast cancer, offers a potential alternative to traditional surgical treatment by using a minimally invasive approach designed with patient experience in mind. The study within its network will be led by Dr. Richard Gilmore, breast surgical oncologist, whose expertise and leadership will help advance research focused on improving breast cancer treatment options. At West, West Cancer Center remain committed to bringing innovative therapies and clinical research opportunities to its patients while continuing to redefine what is possible in cancer care.
West Cancer Center news briefs. May 04, 2026 at 02:55 pm by pjeter West Cancer Center & Research Institute is pleased to announce that Dr. Allison Vaughn Jones has joined their Dermatology Multidisciplinary Clinic. Jones is a highly respected, board certified dermatologist at UT Dermatology and brings extensive experience in diagnosing and managing complex skin conditions, including those that intersect with oncology care. She will be collaborating with Dr. Jason Chandler and Dr. David Portnoy to enhance coordinated care for patients with skin cancers, treatment related dermatologic concerns, and other conditions that benefit from integrated expertise. This is a collaboration between West Cancer Center and Research Institute and the University of Tennessee Health Science Center. Jones will continue her practice at UT as the Assistant Professor of Dermatology at UTHSC, while collaborating with Dr. Portnoy. West Cancer Center & Research Institute has opened a new clinic location in Bartlett. This expansion reflects their continued commitment to increasing access to high-quality cancer care across the Mid-South. The Bartlett office will operate Monday through Thursday and will initially function as a surgery clinic. The following specialists will be providing services at the Bartlett location. Head & Neck Oncology - Dr. Richard Muller Breast Surgical Oncology - Dr. Linda Han Gynecologic Oncology - Dr. Todd Tillmanns Urogynecology - Dr. Ben Abdu Dr. Axel Grothey, medical oncologist and Director of Gastrointestinal Cancer Research at West Cancer Center & Research Institute, recently authored a powerful column in The Tennessean highlighting the urgent need for colorectal cancer screening across Tennessee. Grothey sheds light on the state's high rates of colon cancer diagnoses and deaths, while emphasizing that early detection can dramatically improve outcomes. His column also introduces a promising new FDA-approved blood test - the Shield test - which offers a more convenient, non-invasive screening option for eligible adults. Through his perspective, Grothey reinforces a critical message: one conversation with a doctor and one screening test can truly save lives. A new study published in Nature Publishing Group highlights promising strategies to improve adherence to oral endocrine therapy (AET) among younger breast cancer patients - an area critical to long-term outcomes. Dr. Gregory Vidal co-authored this important research, which examined the impact of app-based remote monitoring on treatment adherence. Findings from this randomized trial demonstrated that premenopausal women using a remote symptom-monitoring app achieved significantly higher 12-month adherence rates compared to usual care (53.9 percent vs. 25.0 percent), while no significant benefit was observed among postmenopausal patients. These results underscore the unique challenges younger patients face and highlight remote monitoring as a scalable, technology-driven approach to help close adherence gaps and improve outcomes. Link: https://www.nature.com/articles/s41523-026-00900-9
West Cancer Center and IDEOlogy Health announce strategic partnership to advance patient-centered oncology education and care. PR Newswire Today at 7:42am PDT MEMPHIS, Tenn. and AUSTIN, Texas, April 7, 2026 /PRNewswire/ - West Cancer Center & Research Institute, the Mid-South's premier provider of comprehensive adult cancer care, and IDEOlogy Health, a leader in delivering non-promotional, multi-channel medical education to oncology professionals, today announced two exclusive strategic partnership agreements designed to elevate physician and Advanced Practice Provider (APP) education. Together, these collaborations aim to strengthen oncology care delivery and improve outcomes for patients across the community. With more than 46 years of oncology expertise, 113 specialized providers, and care provided to more than 68,000 patients annually, West Cancer Center & Research Institute is a nationally recognized model for integrated cancer care. West offers advanced treatments, innovative therapies, and comprehensive patient support services, all grounded in research-driven and compassionate care. IDEOlogy Health is widely recognized for its commitment to "Creating Aha! Moments in Healthcare(R)" and for leading innovation in how healthcare professionals stay current with advancements in medicine. Through expert-led programs, roundtable discussions, and real-time clinical data updates, IDEOlogy Health empowers oncology providers with timely, relevant insights that can impact patient care from day one. A Shared Commitment to Patients This partnership reflects a shared vision between West Cancer Center & Research Institute and IDEOlogy Health: to enhance the patient journey by equipping oncology care teams with high-quality clinical education and practical tools that support exceptional, holistic care. "Our partnership with IDEOlogy Health reflects West Cancer Center & Research Institute's continued commitment to leading the region in advanced, evidence-based oncology care," said Sylvia Richey, MD, Medical Oncologist and Chief Medical Officer for West. "By expanding access to the latest clinical insights and high-quality educational resources, we are strengthening the expertise of our physicians and advanced practice providers. This collaboration further enhances our ability to deliver exceptional, patient centered care across every community we serve." By combining IDEOlogy Health's innovative educational platforms with West's deep clinical expertise, the collaboration will help accelerate the integration of emerging research into everyday clinical practice, ensuring patients benefit from the latest scientific advancements, regardless of where they receive care. "We're thrilled to partner with West Cancer Center to deliver a multi-channel medical education program tailored to the needs of its physicians and advanced practice providers," said Cameron Lush, President of IDEOlogy Health. "This partnership helps ensure care teams have timely access to the latest clinical insights to support the best possible outcomes for patients." About West Cancer Center & Research Institute West Cancer Center & Research Institute is a nationally recognized leader in adult cancer care, offering comprehensive oncology services across multiple locations in the Mid-South. With a mission rooted in research, advanced treatments, prevention, and equitable access to care, West's multidisciplinary team delivers exceptional support to patients and families throughout the entire cancer journey. About IDEOlogy Health IDEOlogy Health, part of The Lockwood Group, is leading the change in how healthcare professionals connect and stay up to date on the latest advancements in medicine. The company leverages decades of healthcare expertise and emerging technology to provide data, analysis, and educational opportunities from experts across the globe in therapeutic areas of Oncology and Hematology. SOURCE IDEOlogy Health This is a paid placement. For further inquiries, please contact PR Newswire directly.
Atlas Oncology Partners, a value-based cancer care company, has officially launched in Memphis, Tennessee, with its first partner, West Cancer Center & Research Institute. The company aims to enhance existing cancer care by embedding support teams within partner practices to guide patients through all phases of treatment. Atlas offers whole-person care coordination, psychosocial support, and management of cancer-adjacent conditions. The company's model includes onsite and virtual care teams working alongside oncologists whilst assuming full medical cost risk. Founded by President Kate Roberts and Chief Medical Officer Dr Gabrielle Rocque, Atlas plans to expand throughout the Southeast in 2026, targeting markets in Alabama, Arkansas, Louisiana, Mississippi and Texas. The company remains in pre-revenue stage whilst establishing its partnership model.
The oncologist with West Cancer Center has been named one of the 2024 Top Doctors in Memphis by the Castle Connolly research group.
West Cancer Center is Hiring for 35 Jobs on Simplify!
Find jobs on Simplify and start your career today
About West Cancer Center
Industries
Education
Healthcare
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Brighton, Colorado
Founded
1979
West Cancer Center is Hiring for 35 Jobs on Simplify!
Find jobs on Simplify and start your career today